Is ZURVY a Good Stock to Buy? The Bull and Bear Case (2026)
Last updated November 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Zurich Insurance Group AG (ZURVY) rests on Commercial and specialty insurance, now with Beazley: Commercial insurance is the core of Zurich's P&C book, and specialty lines are where it is pushing hardest. The bear case rests on catastrophe losses are the most visible risk. Analysts covering it publish targets from $33.00 to $60.20 against a $37.47 share price on November 20, 2026, so even the professionals disagree by 62% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
ZURVY key stats
At $37.47 on November 20, 2026, Zurich Insurance Group AG (ZURVY) has a market cap of $112B, a P/E of 15.2 on trailing earnings (14.4 on forward earnings) and a dividend yield of 5.12%.
- Market cap
- $112B
- P/E (trailing)
- 15.2
- P/E (forward)
- 14.4
- EPS (trailing 12 months)
- $2.47
- Price to book
- 3.5
- Dividend yield
- 5.12%
- Beta
- 0.27
Market cap, P/E and yield are measured at the $37.47 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with Zurich Insurance Group AG (ZURVY)?
The last two weeks for Zurich Insurance Group AG, as of November 22, 2026: the price move, the next earnings date, and what analysts changed.
- ZURVY closed at $37.47 on November 20, 2026, down 4.0% over the past five trading days (from $39.03).
Prices are daily closes from Yahoo Finance. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
Zurich Insurance Group AG is one of Europe's largest insurers, founded in 1872 and based in Zurich, with about 60,000 employees. It reports three businesses. Property and casualty (P&C) is the biggest: commercial insurance for companies of every size, including the Global Specialty lines, plus retail motor and home cover. Life sells protection and savings products, mostly in Europe, Latin America and Asia Pacific. Farmers is the odd one out. Zurich owns Farmers Group, Inc., which runs the US Farmers Exchanges for a management fee; the exchanges belong to their policyholders, so Zurich earns fee income without carrying their underwriting risk. Fiscal 2025 was a record. Business operating profit rose 14% to about US$8.9 billion, net income attributable to shareholders reached ~US$6.8 billion, P&C gross written premiums passed US$50 billion for the first time and the dividend rose 7% to CHF 30 a share. The first half of 2026 kept going: operating profit up 13% to US$4.77 billion, net income up 14% to US$3.49 billion and core earnings per share up 11.5% to US$24.2. The P&C combined ratio was 92.7%, slightly worse than 92.4% a year earlier, while Life operating profit jumped 23% and Farmers came in below analyst estimates. The nine-month trading update on 12 November showed P&C premiums of US$42.1 billion, up 7% like for like, and a Swiss Solvency Test (SST) ratio of 271%. The biggest change this year is Beazley, the Lloyd's of London specialty insurer, which Zurich bought for 1,310 pence a share in cash (about £8.1 billion), completing on 1 October 2026. Zurich paid for it with a CHF 3.9 billion share placement at CHF 550, roughly US$3.0 billion of existing cash and about US$2.9 billion of new debt. In Zurich the shares closed at CHF 652 on 17 November, up about 8% in 2026 and near their 52-week high of CHF 661.60, for a market value of roughly CHF 98 billion. In the US, ZURVY closed at US$38.83 that day, up only about 2% this year because the dollar firmed against the franc. It then slipped to US$37.70 by 20 November 2026, leaving it down about 0.9% year to date and up about 9.2% over twelve months, inside a 52-week range of about US$33.62 to US$39.61. The dip came in a week when Barclays turned bearish on European insurers, arguing that their share price rally had run ahead of earnings growth. On the 2025 core earnings of ~US$45 a share the stock trades at roughly 17 times (a premium to most European peers), while Yahoo Finance's ADR-based figures show about 15 times trailing and 14.5 times forward earnings.
The bull case: what would have to be true for $60.20
The most optimistic published target on ZURVY is $60.20, +60.7% from the $37.47 share price on November 20, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Commercial and specialty insurance, now with Beazley
Commercial insurance is the core of Zurich's P&C book, and specialty lines are where it is pushing hardest. In the first nine months of 2026 commercial premiums grew 5%, Global Specialty 9% and US construction 17%, while middle market rose 6%. Beazley adds a large Lloyd's platform in cyber, property, marine and other specialty risks, and gives Zurich its first direct presence at Lloyd's. Kristof Terryn now runs Beazley together with Zurich Global Specialty. The return on an £8.1 billion price depends on keeping Beazley's underwriters and brokers, holding its loss ratios, and finding cost and capital savings from putting the two specialty books under one roof.
2. Retail P&C pricing
Retail is the faster-growing half of P&C this year. Retail premiums rose 9% in the nine months to September, with motor up 14%, as rate increases of about 4% flowed through. That contrasts with commercial rates, which fell about 1%, mostly in large property, where capacity has returned after several profitable years. Retail motor and home are less exposed to that softening, and Asia Pacific P&C grew 9% on retail motor and commercial middle market. The question for 2027 is whether retail rates keep running ahead of claims inflation, since motor repair costs and weather-related home claims have both risen faster than general prices in recent years.
3. Life growth and the ClearView deal
Life is the steadier earnings stream and grew faster than expected in 2026. Operating profit rose 23% to US$1.27 billion in the first half, and management raised its full-year Life growth guidance to at least 10% from a mid-to-high single-digit range. Life gross written premiums reached US$28.6 billion in the nine months, up 3%. In Australia, Zurich completed the purchase of ClearView Wealth on 20 August 2026 for 60 Australian cents a share in cash, adding a third life brand there. Life profits come mainly from protection and fee-based savings products, which tie up less capital than traditional guaranteed savings business.
4. Capital, Farmers fees and the dividend
Zurich's SST ratio was an estimated 271% at the end of September, up from 266% in June. That figure does not yet include Beazley or the new shares issued to fund it, so the post-deal ratio will be lower. The dividend policy targets a payout of about 75% of net income attributable to shareholders, with the prior year's dividend as a floor, which is why the payout has risen each year from CHF 28 for 2024 to CHF 30 for 2025. Farmers adds fee income: the Farmers Exchanges wrote US$23.5 billion of premiums in the nine months, up 4%, and added 342,000 policies, though Farmers operating profit missed estimates in the first half.
The bear case: what would have to be true for $33.00
The most pessimistic published target is $33.00, -11.9% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks Zurich Insurance Group AG is worth if the risks below bite instead of the drivers above.
Catastrophe losses are the most visible risk. Zurich's catastrophe loss ratio rose to 3.2% in the first nine months of 2026 from 1.4% a year earlier after third-quarter storms in Switzerland, Germany and Italy, and a severe US hurricane or European flood season can take a large bite out of a year's P&C profit. The commercial pricing cycle is turning: rates fell about 1% in the nine months, and a longer soft market would squeeze margins in the lines where Zurich and Beazley are biggest. Beazley brings integration risk at a large price, plus exposure to cyber and Lloyd's specialty lines that can produce volatile losses; the deal also added about US$2.9 billion of new debt and roughly 7.1 million new shares. US casualty reserves are an industry-wide concern, since lawsuit costs have pushed older claims above their reserves at several insurers. Farmers depends on the health of the Farmers Exchanges, which Zurich manages but does not own. Mario Greco has run Zurich since 2016, so succession is a live question. For US holders, the franc-dollar rate moves the ADR independently of the business, and the 35% Swiss withholding tax on dividends needs paperwork to reclaim. Sector sentiment is a further swing factor: in November 2026 Barclays turned bearish on European insurers as a group, saying their rally had outpaced earnings growth, and the three analysts Yahoo Finance tracks on the ADR have a hold consensus.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding ZURVY already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on ZURVY
3 analysts cover ZURVY, with an average target of $43.65 (+16.5% against $37.47) and a split of 1 buy, 1 hold, 1 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the ZURVY forecast and price target page.
How is ZURVY valued?
Market cap, P/E and dividend yield at today's price are in the ZURVY key stats above. The business figures below come from Zurich Insurance Group AG's reported results as of November 2026 and change when it next reports.
- Home share price (SIX, 17 Nov 2026): ~CHF 652
- Market value: ~US$113 billion (Yahoo Finance)
- Business operating profit (FY2025): ~US$8.9 billion
- Net income (TTM): ~US$7.2 billion
- Price to 2025 core EPS: ~17x (Yahoo ADR-based P/E ~15x trailing, ~14.5x forward)
- Dividend (FY2025): CHF 30 a share, ~5.1% yield on the ADR per Yahoo Finance
As of November 2026: Zurich reports in US dollars, pays its dividend in Swiss francs and trades in francs on SIX, so every ratio mixes currencies. At CHF 652 a share on 17 November (about US$777 at the rate implied by the ADR that day) and core earnings of about US$45 a share for 2025, the stock traded near 17 times trailing earnings and roughly 16 times an annualised first-half 2026 run rate of US$24.2; Yahoo Finance's figures for the ADR at US$37.70 on 20 November show about 15 times trailing and 14.5 times forward. Core return on equity was about 27% in 2025. The dividend yield is a gross Swiss figure, before the 35% withholding tax, and moves with the franc-dollar rate. The three analysts Yahoo Finance tracks on the ADR have a mean target near US$43.65 and a hold rating.
How do you decide if ZURVY is a buy?
Whether ZURVY is a buy is easier to judge through four narrower questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold ZURVY indirectly through an index or sector ETF before adding more.
What would change your mind on ZURVY
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Commercial and specialty insurance, now with Beazley stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
- Bear case breaks if: catastrophe losses are the most visible risk fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the ZURVY stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about ZURVY against your real portfolio and see your actual exposure before deciding.
Your questions about Zurich Insurance Group AG
Ask Walnut's AI anything about ZURVY and see how it fits what you own.
FAQ
Is ZURVY a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Commercial and specialty insurance, now with Beazley, with price to 2025 core eps at ~17x (Yahoo ADR-based P/E ~15x trailing, ~14.5x forward). The bear case rests on catastrophe losses are the most visible risk. Analysts covering it are spread from $33.00 to $60.20, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.
Should I sell ZURVY?
+
Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Catastrophe losses are the most visible risk. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $33.00, -11.9% from the $37.47 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.
What is the bull case for ZURVY?
+
Commercial and specialty insurance, now with Beazley. Commercial insurance is the core of Zurich's P&C book, and specialty lines are where it is pushing hardest. The most optimistic analyst target on ZURVY is $60.20, +60.7% from the $37.47 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for ZURVY?
+
Catastrophe losses are the most visible risk. Zurich's catastrophe loss ratio rose to 3.2% in the first nine months of 2026 from 1.4% a year earlier after third-quarter storms in Switzerland, Germany and Italy, and a severe US hurricane or European flood season can take a large bite out of a year's P&C profit. The commercial pricing cycle is turning: rates fell about 1% in the nine months, and a longer soft market would squeeze margins in the lines where Zurich and Beazley are biggest. Beazley brings integration risk at a large price, plus exposure to cyber and Lloyd's specialty lines that can produce volatile losses; the deal also added about US$2.9 billion of new debt and roughly 7.1 million new shares. US casualty reserves are an industry-wide concern, since lawsuit costs have pushed older claims above their reserves at several insurers. Farmers depends on the health of the Farmers Exchanges, which Zurich manages but does not own. Mario Greco has run Zurich since 2016, so succession is a live question. For US holders, the franc-dollar rate moves the ADR independently of the business, and the 35% Swiss withholding tax on dividends needs paperwork to reclaim. Sector sentiment is a further swing factor: in November 2026 Barclays turned bearish on European insurers as a group, saying their rally had outpaced earnings growth, and the three analysts Yahoo Finance tracks on the ADR have a hold consensus. The most pessimistic published target is $33.00, -11.9% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.
What does Zurich Insurance Group AG do?
+
One of Europe's largest insurers, founded in 1872, writing property-casualty and life cover worldwide, with Farmers in the US.
What would have to change for ZURVY to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Commercial and specialty insurance, now with Beazley) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (catastrophe losses are the most visible risk) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What is ZURVY and how does the ADR work?
+
ZURVY is a sponsored American Depositary Receipt for Zurich Insurance Group, issued by The Bank of New York Mellon as depositary. Each ADR represents one twentieth of an ordinary Zurich share, so 20 ADRs equal one share listed on the SIX Swiss Exchange under the ticker ZURN. The ADR trades over the counter on OTCQX in US dollars during US market hours, and its price tracks the Swiss share price converted at the current franc-dollar rate. On 17 November 2026 the shares closed at CHF 652 and ZURVY at US$38.83, which implies about US$1.19 per franc. A separate OTC line, ZFSVF, quotes the ordinary shares themselves and trades far less. Because the ADR is not exchange-listed, it may not be available at every US broker, and spreads can be wider than on a large NYSE stock.
How does Zurich Insurance make money?
+
Zurich earns most of its profit from property and casualty insurance, which produced about US$5.1 billion of operating profit in 2025. It collects premiums, pays claims and keeps the gap, plus investment income on the money it holds before claims are paid. Its combined ratio, claims plus expenses as a share of premiums, was 92.7% in the first half of 2026, meaning about 7 cents of underwriting profit per dollar of premium. Life insurance added about US$2.3 billion of operating profit in 2025, from protection and savings products. Farmers added about US$2.4 billion: Zurich's Farmers Group runs the policyholder-owned Farmers Exchanges in the US for a management fee, so that income depends on the exchanges' premium volume, not their claims.
What did Zurich report most recently?
+
On 12 November 2026 Zurich published a nine-month trading update with no profit figures. P&C gross written premiums were US$42.1 billion, up 7% like for like, with retail up 9% and commercial up 5%. Life premiums rose 3% to US$28.6 billion and the Farmers Exchanges' premiums rose 4% to US$23.5 billion. The catastrophe loss ratio rose to 3.2% from 1.4% after summer storms in Europe, and commercial rates fell about 1%. The SST ratio was 271%. The last full results, for the first half, showed business operating profit up 13% to US$4.77 billion and net income up 14% to US$3.49 billion. Full-year 2026 results are expected in February 2027 and will be the first to include Beazley.
Walnut is informational, not investment advice, and gives no verdict on ZURVY. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 20, 2026. Verify current figures with your broker before acting on them.